These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22570292)

  • 1. Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions.
    Khandelwal N; Duncan I; Ahmed T; Rubinstein E; Pegus C
    J Natl Compr Canc Netw; 2012 May; 10(5):618-25. PubMed ID: 22570292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of clinical oral chemotherapy program on wastage and hospitalizations.
    Khandelwal N; Duncan I; Ahmed T; Rubinstein E; Pegus C
    Am J Manag Care; 2011 May; 17(5 Spec No):e169-73. PubMed ID: 21711067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of clinical oral chemotherapy program on wastage and hospitalizations.
    Khandelwal N; Duncan I; Ahmed T; Rubinstein E; Pegus C
    J Oncol Pract; 2011 May; 7(3 Suppl):e25s-9s. PubMed ID: 21886508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated Cost and Savings in a Patient Management Program for Oral Oncology Medications: Impact of a Split-Fill Component.
    Staskon FC; Kirkham HS; Pfeifer A; Miller RT
    J Oncol Pract; 2019 Oct; 15(10):e856-e862. PubMed ID: 31465250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication days' supply, adherence, wastage, and cost among chronic patients in Medicaid.
    Taitel M; Fensterheim L; Kirkham H; Sekula R; Duncan I
    Medicare Medicaid Res Rev; 2012; 2(3):. PubMed ID: 24800150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization patterns for oral oncology medications in a specialty pharmacy cycle management program.
    Deutsch S; Koerner P; Miller RT; Craft Z; Fancher K
    J Oncol Pharm Pract; 2016 Feb; 22(1):68-75. PubMed ID: 25301744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.
    Middendorff G; Elsey R; Lounsbery B; Chadwell R
    J Oncol Pharm Pract; 2018 Jul; 24(5):371-378. PubMed ID: 28509613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an integrated oral chemotherapy program on patient adherence.
    Morgan KP; Muluneh B; Deal AM; Amerine LB
    J Oncol Pharm Pract; 2018 Jul; 24(5):332-336. PubMed ID: 28379068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost savings from dose rounding of biologic anticancer agents in adults.
    Winger BJ; Clements EA; DeYoung JL; O'Rourke TJ; Claypool DL; Vachon S; VanDyke TH; Zimmer-Young J; Kintzel PE
    J Oncol Pharm Pract; 2011 Sep; 17(3):246-51. PubMed ID: 20332175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
    Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
    J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial impact of oral chemotherapy wastage on society and the patient.
    Monga V; Meyer C; Vakiner B; Clamon G
    J Oncol Pharm Pract; 2019 Jun; 25(4):824-830. PubMed ID: 29575989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.
    Yamada H; Kobayashi R; Shimizu S; Yamada Y; Ishida M; Shimoda H; Kato-Hayashi H; Fujii H; Iihara H; Tanaka H; Suzuki A
    Int J Clin Pract; 2020 Apr; 74(4):e13464. PubMed ID: 31830345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.
    Gebbia V; Bellavia G; Ferraù F; Valerio MR
    Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S49-59. PubMed ID: 22149481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines.
    Matti N; Delon C; Rybarczyk-Vigouret MC; Khan GM; Beck M; Michel B
    Int J Clin Pharm; 2020 Oct; 42(5):1311-1318. PubMed ID: 32857257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome Assessments and Cost Avoidance of an Oral Chemotherapy Management Clinic.
    Wong SF; Bounthavong M; Nguyen CP; Chen T
    J Natl Compr Canc Netw; 2016 Mar; 14(3):279-85. PubMed ID: 26957614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents.
    Doshi JA; Li P; Huo H; Pettit AR; Armstrong KA
    J Clin Oncol; 2018 Feb; 36(5):476-482. PubMed ID: 29261440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
    Divakaruni A; Saylor E; Duffy AP
    J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.